| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 1. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | dutasteride/tamsulosin hydrochloride (Combodart®) |
| Formulation | 0.5 mg/0.4 mg capsule |
| Reference number | 724 |
| Indication | Treatment of moderate to severe symptoms of benign prostatic hyperplasia (BPH) and the reduction in the risk of acute urinary retention and surgery in patients with moderate to severe symptoms of BPH |
| Company | GlaxoSmithKline |
| BNF chapter | Endocrine system |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 01/06/2010 |